These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29618137)

  • 21. Connecting molecular pathways to hereditary cancer risk syndromes.
    Testa JR; Malkin D; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
    Imperiale A; Moussallieh FM; Roche P; Battini S; Cicek AE; Sebag F; Brunaud L; Barlier A; Elbayed K; Loundou A; Bachellier P; Goichot B; Stratakis CA; Pacak K; Namer IJ; Taïeb D
    Neoplasia; 2015 Jan; 17(1):55-65. PubMed ID: 25622899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.
    Lee S; Nakamura E; Yang H; Wei W; Linggi MS; Sajan MP; Farese RV; Freeman RS; Carter BD; Kaelin WG; Schlisio S
    Cancer Cell; 2005 Aug; 8(2):155-67. PubMed ID: 16098468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel hereditary forms of pheochromocytomas and paragangliomas.
    Dahia PL
    Front Horm Res; 2013; 41():79-91. PubMed ID: 23652672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations.
    Smestad JA; Maher LJ
    BMC Cancer; 2019 Jun; 19(1):619. PubMed ID: 31234811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
    Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
    Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic Urine Profile: Searching for New Biomarkers of SDHx-Associated Pheochromocytomas and Paragangliomas.
    Martins RG; Gonçalves LG; Cunha N; Bugalho MJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5467-5477. PubMed ID: 31504671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of the SDHB and SDHD genes.
    Pawlu C; Bausch B; Neumann HP
    Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas.
    Turchini J; Gill AJ
    Am J Surg Pathol; 2020 Mar; 44(3):422-424. PubMed ID: 31789631
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma.
    Osinga TE; Xekouki P; Nambuba J; Faucz FR; de la Luz Sierra M; Links TP; Kema IP; Adams K; Stratakis CA; van der Horst-Schrivers AN; Pacak K
    Horm Metab Res; 2016 Apr; 48(4):247-50. PubMed ID: 26916530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathways linking the pheochromocytoma susceptibility genes.
    Leow MK
    Pediatr Blood Cancer; 2007 Dec; 49(7):1050-1; author reply 1052-3. PubMed ID: 17243134
    [No Abstract]   [Full Text] [Related]  

  • 37. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL;
    Ann N Y Acad Sci; 2006 Aug; 1073():208-20. PubMed ID: 17102089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
    Gimm O
    Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of mRNAs for succinate dehydrogenase subunits and related genes in pheochromocytoma.
    Isobe K; Nissato S; Tatsuno I; Yashiro T; Takekoshi K; Kawakami Y
    Ann N Y Acad Sci; 2006 Aug; 1073():253-62. PubMed ID: 17102093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.